Transcatheter mitral valve repair and replacement is a minimally invasive technique for the treatment of heart-associated diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. In case of mitral valve misfunctioning, an individual can experience symptom such as fatigue and shortness of breath. Mitral valve diseases occurs when mitral valve does not pump enough blood out of the left ventricular chamber to supply the body with oxygen-filled blood. Mitral valve disorders are severe, if untreated, they may lead to heart failure and irregular heartbeats called arrhythmias.
The major factors that drive the growth of the global transcatheter mitral valve repair and replacement market include increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves. However, implementation of stringent regulations by governing bodies for the approval of novel mitral valve stents, high cost of mitral valve surgeries, and risks associated with this procedure restrain the market growth. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.
The global transcatheter mitral valve repair and replacement market is segmented into product, indication, and region. According to product, the market is divided into mechanical valves and bioprosthetic tissue (biological) valves. By indication, it is categorized into mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.
The major factors that drive the growth of the global transcatheter mitral valve repair and replacement market include increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves. However, implementation of stringent regulations by governing bodies for the approval of novel mitral valve stents, high cost of mitral valve surgeries, and risks associated with this procedure restrain the market growth. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.
The global transcatheter mitral valve repair and replacement market is segmented into product, indication, and region. According to product, the market is divided into mechanical valves and bioprosthetic tissue (biological) valves. By indication, it is categorized into mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the transcatheter mitral valve repair & replacement market analysis from 2020 to 2030 to identify the prevailing transcatheter mitral valve repair & replacement market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the transcatheter mitral valve repair & replacement market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global transcatheter mitral valve repair & replacement market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Indications
- Mitral Valve Stenosis
- Mitral Valve Prolapse
- Mitral Valve Regurgitation
BY PRODUCT
- Mechanical Valves
- Bioprosthetic Tissue (Biological) Valves
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- ABBOTT LABORATORIES
- BIOTRONIK SE & CO. KG
- COLIBRI HEART VALVE, LLC.
- EDWARDS LIFE SCIENCE CORPORATION
- HLT, INC.
- LIVANOVA PLC
- MEDTRONIC PLC
- NEOVASC INC.
- NEOCHORD INC.
- CORAMAZE TECHNOLOGIES GMBH.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY PRODUCT
CHAPTER 5: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY INDICATIONS
CHAPTER 6: TRANSCATHETER MITRAL VALVE REPAIR & REPLACEMENT MARKET, BY REGION
CHAPTER 7: COMPANY LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Executive Summary
According to this report titled, 'Transcatheter Mitral Valve Repair & Replacement Market,' the Transcatheter Mitral Valve Repair & Replacement Market was valued at $801.60 million in 2020, and is estimated to reach $3.2 billion by 2030, growing at a CAGR of 14.8% from 2021 to 2030.Mitral valve, also known as the bicuspid valve or left atrioventricular valve, which is located between the left atrium and the left ventricle of the heart. Mitral valve repair or replacement is necessary when the blood starts flowing backward, which occurs due to narrowing of the valve or due heart associated infections such as endocarditis. Two types of mitral valves are available for replacement-mechanical and bioprosthetic valves. Mechanical valves are made of materials such as carbon and titanium, whereas bioprosthetic valves are made from tissues of animals such as pig and cows. Transcatheter Mitral Valve Repair & Replacement Market is a minimally invasive technique for the treatment of heart-associated diseases such as mitral valve stenosis, mitral valve prolapses, and mitral valve regurgitation, also such minimally invasive procedures, which have certain benefits such as shorter recovery time, less stay in hospitals, less pain, fewer wound complications, and better wound coSMEsis. In minimally invasive surgeries, a surgeon generally makes a 5cm cut on the right side of the chest and gently opens up the space between ribs to gain entry to the heart. Further, a high definition video camera is used to guide the procedure inside the heart and then the procedure is continued for mitral valve repair or replacement. Therefore, due to the various advantages mentioned above of minimally invasive mitral valve surgeries, most of the surgeon’s advice the patients to opt for transcatheter mitral valve surgeries which further supplement the growth of transcatheter mitral valve repair and replacement market.
Increase in incidence of heart diseases especially among the geriatric population, technological advancements, and introduction of novel mitral valves are expected to drive the TMVR Market growth However, implementation of stringent regulations by governing bodies for approval of novel mitral valve stents as well as lack of awareness among healthcare professionals impede the growth of TMVR Market Size. Conversely, continuous product innovations and introduction of novel mitral valves in untapped economies are anticipated to create lucrative opportunities for key market players.
On the basis of product in TMVR Market Share, the transcatheter mitral valve repair and replacement market is categorized as mechanical valves and bioprosthetic tissue (biological) valves. The mechanical valves segment is expected to dominate the market throughout the TMVR Market Analysis period, owing to rise in geriatric population and increase in incidences of heart valve disorders. In addition, varied benefits associated with mechanical mitral valves such as increased durability and lower complication as compared to bioprosthetic valves boost the market growth. The bioprosthetic tissue (biological) valves segment is expected to register a CAGR of 14.3% during the TMVR Market Forecast period, owing to the need for bio compatible mitral valves for the geriatric population for reducing the complications caused post surgery.
On the basis of indication, the mitral valve regurgitation segment accounted for a major share of the market share in the transcatheter mitral valve repair and replacement market in 2020. This segment is expected to exhibit a prominent growth rate, owing due to the prevalence of mitral valve regurgitation and sudden deaths, which are responsible for approximately $ a quarter of the deaths occurring under medical treatment.
North America in TMVR Industry, accounted for more than 14.6% of the global market share in 2020, and is expected to remain dominant throughout the forecast period, owing to rise in number of high-risk or inoperable severe mitral stenosis patients in the region. In addition, sophisticated healthcare infrastructure, increased awareness among cardiologists, and patients for transcatheter mitral valve repair and replacement are set to boost the market growth. Asia-Pacific is projected to register the highest CAGR of 16.0% during the forecast period, the prevalence of mitral valve diseases and deaths caused owing to this disease are the key reasons that increase the growth of this market.
The major companies profiled in the report of TMVR Industry include in LivaNova Plc., Abbott Laboratories, Biotronik Pvt., Ltd., Edward Lifesciences, Medtronic Plc., Neovasc Inc., NeoChord, St. Jude Medical, Direct Flow Medical Inc., and Colibri Heart Valve, LLC.
Key findings of the Study
- The mechanical valves segment accounted for 15.2% of the global market in 2020.
- The mitral valve regurgitation segment accounted for 16.7% share of the market in 2020.
- U.S. was the major shareholder in the North America transcatheter mitral valve repair & replacement market, and accounted for the highest share in 2020
- Asia-Pacific is expected to register the highest CAGR of 16.0% during the forecast period.
Companies Mentioned
- ABBOTT LABORATORIES
- BIOTRONIK SE & CO. KG
- COLIBRI HEART VALVE, LLC.
- EDWARDS LIFE SCIENCE CORPORATION
- HLT, INC.
- LIVANOVA PLC
- MEDTRONIC PLC
- NEOVASC INC.
- NEOCHORD INC.
- CORAMAZE TECHNOLOGIES GMBH.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
